BRIEF published on 11/06/2024 at 10:39, 2 years ago HiPay Group Announces 2025 Financial Calendar General Meeting HiPay Group Financial Calendar 2025 Revenue Release Investor Dates
BRIEF published on 11/06/2024 at 10:39, 2 years ago Le Groupe HiPay annonce son calendrier financier 2025 Assemblée Générale Groupe HiPay Calendrier Financier 2025 Publication Des Revenus Dates Pour Les Investisseurs
PRESS RELEASE published on 11/06/2024 at 10:37, 2 years ago HiPay Group - Calendrier Financier 2025 HiPay (code ISIN FR0012821916 – ALHYP) présente son calendrier financier de l’année 2025 avec des dates indicatives pour les principaux événements. Contact: Eric Meynard Calendrier Financier 2025 HiPay Eric Meynard Dates Indicatives
PRESS RELEASE published on 11/06/2024 at 10:34, 2 years ago HiPay Group - 2025 Financial Calendar HiPay presents its financial calendar for 2025, featuring key events and dates for investors. Visit hipay.com for more information Forward-looking Statements Investor Relations Financial Calendar 2025 HiPay
BRIEF published on 09/16/2024 at 19:44, 2 years 1 month ago Résultats Semestriels 2024 de HIPAY GROUP Chiffre D'affaires Résultats Financiers EBITDA 2024 HiPay Group
BRIEF published on 09/16/2024 at 19:44, 2 years 1 month ago HIPAY GROUP 2024 Half-Year Results Financial Results EBITDA 2024 Turnover HiPay Group
PRESS RELEASE published on 09/16/2024 at 19:39, 2 years 1 month ago Résultats Semestriels au 30-06-2024 HiPay annonce des résultats positifs pour le S1 2024 avec croissance du volume de paiements et du chiffre d'affaires. EBITDA en hausse et résultats nets satisfaisants Croissance EBITDA Résultats Paiement HiPay
BRIEF published on 07/29/2024 at 22:28, 2 years 3 months ago HiPay : croissance de 10,5% du chiffre d'affaires au premier semestre 2024 Croissance International Fintech IGaming Paiement Omnicanal
BRIEF published on 07/29/2024 at 22:28, 2 years 3 months ago HiPay: growth of 10.5% in turnover in the first half of 2024 International Growth Fintech IGaming Omnichannel Payment
PRESS RELEASE published on 07/29/2024 at 22:28, 2 years 3 months ago Half-Year Consolidated revenue as at June 30th 2024 HiPay announces 10.5% revenue growth in H1 2024, driven by strong sales performance amidst challenging economic environment Revenue Growth Payment Solutions Financial Update HiPay H1 2024
Published on 11/06/2026 at 22:15, 2 days 10 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 19 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 19 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 08:05, 9 minutes ago Onodrim Industries secures $300 million Series A at $1.3 billion valuation to strengthen Europe's defence and industrial foundations
Published on 11/09/2026 at 08:00, 15 minutes ago Custodian Property Income REIT plc: Further momentum with majority share-based acquisition strategy, purchasing an £11.0m property portfolio from eight syndicated investment vehicles
Published on 11/09/2026 at 08:00, 15 minutes ago Eleving Group achieves record-high net profit of EUR 27.8 million in the first nine months of 2026
Published on 11/09/2026 at 07:00, 1 hour 15 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 1 hour 15 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 1 hour 15 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 1 hour 15 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 13 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
